AzTrials
AzTrials

Family MembersNCT06859112

The Effect Of Logotherapy-Based Psychoeducatıon Applıed To Famıly Members Of Indıvıduals Dıagnosıs Of Schızophrenıa

A study testing logotherapy focused psychoeducation in people with Family Members and Healthy, run by aslı zeynep sipahi at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Objective: This study aimed to determine the effects of logotherapy-based psychoeducation applied to family members of individuals diagnosed with schizophrenia on meaning in life, hope, and depression, and to examine experiences related to the psychoeducation process. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Family Members, Healthy
What is being tested?
logotherapy focused psychoeducation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
42 participants
Where
1 siteTurkey (Türkiye)
Study dates
22 Dec 2023to 15 Sep 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

None listed.

Who cannot join

  • Failure to attend at least two psychoeducation sessions in total
  • Failure to complete or incomplete completion of data collection forms

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Uskudar University

    Ümraniye, Istanbul, 34768

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect Of Logotherapy-Based Psychoeducatıon Applıed To Famıly Members Of Indıvıduals Dıagnosıs Of Schızophrenıa On Meanıng In Lıfe, Hope And Depressıon And Theır Psychoeducatıon Experıences

Objective: This study aimed to determine the effects of logotherapy-based psychoeducation applied to family members of individuals diagnosed with schizophrenia on meaning in life, hope, and depression, and to examine experiences related to the psychoeducation process.

Materials and Methods: Using a parallel convergent mixed methods design, the quantitative dimension of the study was designed as a randomized controlled trial, and the qualitative dimension was designed using a phenomenological method. The research was conducted between November 2023 and August 2025 with family members of individuals diagnosed with schizophrenia who were being followed up in the mental health and diseases outpatient clinics of a city hospital in Istanbul. A total of 40 family members were included in the study, 19 in the experimental group and 21 in the control group. Quantitative data were collected using the Demographic Information Form, Meaning in Life Scale, Herth Hope Scale, and Beck Depression Inventory, while qualitative data were collected using a Semi-Structured Interview Form. Pre-test measurements were performed on family members in both the experimental and control groups after randomization. Subsequently, individuals in the experimental group received an eight-session Logotherapy-Based Psychoeducation program individually online. Family members who completed the psychoeducation program underwent post-test measurements the following day, and qualitative data were collected through individual in-depth interviews. Family members in the control group received no intervention for eight weeks, after which post-test measurements were taken. Quantitative data were analyzed using the Wilcoxon signed-rank test, Mann Whitney U test, and t-test; qualitative data were analyzed using Colaizzi's phenomenological data analysis method.

Read the detailed description

The resources that will strengthen the family members who play a key role in the treatment of schizophrenia should also be activated. One of these resources that enable people to cope with the difficult events they experience is finding meaning in life. The meaning of life is a basic source of motivation for an individual to live despite everything. In this respect, meaning is a source that helps them maintain their mental balance. Another concept that is considered important in terms of protecting and strengthening the mental health of family members is hope. Hope is defined as setting a goal and taking action to achieve it, and looking for different ways when faced with difficulties. Hope gives caregivers the belief that they can cope with stressful experiences. Therefore, it is important to develop hope in family members of individuals with mental disorders. Today, different therapy methods are applied to protect and improve mental health. Recent studies have shown that logotherapy is an effective method in strengthening positive psychological factors and coping with negative emotions. Logotherapy adopts "Therapy through Meaning" as its basic method. The effectiveness of logotherapy on meaning and hope has been demonstrated in many different samples. No study has been found that focuses on meaning and hope in family members of schizophrenia patients. This research, conducted using a parallel convergent mixed methods design, aims to determine the effects of logotherapy-based psychoeducation applied to family members of individuals diagnosed with schizophrenia on meaning in life, hope, and depression, and to examine experiences related to the psychoeducation process.

Research hypotheses for the quantitative dimension of the study:

  1. Hypothesis (H1a): Beck Depression Inventory scores of the experimental group after intervention are lower than their pre-intervention scores.
  2. Hypothesis (H1b): Herth Hope Scale scores of the experimental group after intervention are higher than their pre-intervention scores.
  3. Hypothesis (H1c): Meaning of Life Scale scores of the experimental group after intervention are higher than their pre-intervention scores.
  4. Hypothesis (H1d): Beck Depression Inventory scores of the experimental group after intervention are lower than those of the control group.
  5. Hypothesis (H1e): Herth Hope Scale scores of the experimental group after intervention are higher than those of the control group.
  6. Hypothesis (H1f): Meaning of Life Scale scores of the experimental group after intervention are higher than those of the control group.

Research question for the qualitative dimension of the study:

What are the experiences of family members who participated in the Logotherapy-Based Psychoeducation Program during the psychoeducation process?

Research question for the mixed research method:

How are the quantitative findings of the study related to the qualitative findings obtained from the interviews, and how do they contribute to solving the research problem when considered together? The study consisted of two groups, an experimental group and a control group, selected through randomization. Each participant was scheduled for a pre-test date, and the Demographic Information Form, Meaning of Life Scale (MLS), Herth Hope Scale (HHS), and Beck Depression Inventory were administered online via Zoom. The following day, the psychoeducation program for family members in the experimental group began with individual online sessions. Eight individual online sessions were conducted with each family member. One day after the completion of the psychoeducation process for each participant, the MLS, HHS, and Beck Depression Inventory were administered again online. On the same day, individual in-depth interviews were conducted using a semi-structured interview form, and qualitative data were collected.

In the control group, each participant underwent individual online post-tests eight weeks after the pre-tests. Following the post-tests, participants in the control group were informed that they could participate in the psychoeducation program if they wished. Four participants from the control group received the psychoeducation program.

The logotherapy-based psychoeducational program was conducted individually via ZOOM in a total of eight sessions, with one meeting per week. Each session lasted 40-60 minutes. Key points to consider during the sessions were highlighted.

One day after the intervention was completed, participants were interviewed online again for final tests, and qualitative data were collected through one-hour in-depth interviews using a Semi-Structured Interview Form.

Since this research is a randomized controlled trial, the experimental process was conducted in accordance with the Consolidated Standards of Reporting Trials (CONSORT-SPI 2018) report.

Being tested
logotherapy focused psychoeducation
Keywords
schizophrenia, family members, logotherapy, nursing, hope, depression, meaning
Medical subject headings
Schizophrenia, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • logotherapy focused psychoeducationOther

    8 sessions of online individual logotherapy focused psychoeducation program

Study groups in NCT06859112
Study groupRoleWhat they receive
Relatives of patients who underwent the applicationExperimentalIndividuals in this group will receive 8 sessions of psychoeducation focused on logotherapy.
Receives: Other: logotherapy focused psychoeducation
relatives of patients in routine practiceNo interventionIndividuals in this arm will not be subjected to any additional intervention other than routine practices.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Finding meaning in life scale score

    The meaning of life scale was developed by Steger and colleagues to determine the meaning people find in life and the meaning they seek. The adaptation study for Turkey was conducted by Akın and Taş. The meaning of life scale consists of 10 items on a 7-point Likert type. The scale consists of two subscales, namely current meaning and sought meaning. The total score on the scale varies between 7 and 70. High scores obtained from the scale indicate that the individual has a high level of meaning in life. The internal consistency reliability coefficients of the scale are .82 for the current meaning subscale and .87 for the sought meaning subscale.

    Measured: first week and eighth week

  2. Herth Hope Scale Scores

    The Herth Hope Scale (HUÖ) was developed by Dr. Herth in 1991 to determine the hope levels of individuals and was adapted to Turkish by Aslan and colleagues. The scale is a four-point Likert type and consists of 30 items. The scale consists of the sub-dimensions "Future", "Positive readiness and expectation" and "Relationships between oneself and those around oneself". The total hope score varies between 0-90, and the total score for each sub-scale varies between 0-30. High scores obtained from the scale indicate a high level of hope. In the reliability study of the Turkish form of the scale, the Cronbach alpha coefficient was determined as 0.84.

    Measured: first week and eighth week

  3. Beck Depression Inventory Scores

    Developed by Beck et al. (1961), the Turkish validity and reliability study was conducted by Hisli (1989) (Beck et al., 1961; Sahin, 1989). The scale, designed to measure physical, emotional, cognitive, and motivational components, is a four-point Likert-type scale. It consists of 21 questions and is rated from 0 to 3. The lowest possible score is 0, and the highest is 63. As the total score increases, the level of depression increases. In terms of severity, 0-9 indicates minimal, 10-16 mild, 17-29 moderate, and 30-63 severe depressive symptoms. Hisli found the Cronbach's alpha value of the scale to be 0.80. In this study, the Cronbach's alpha value was calculated as 0.86 for the pre-test and 0.86 for the post-test.

    Measured: first week and eighth week

  4. Results of semi-structured qualitative form

    The semi-structured interview form to be used for the qualitative interview will be created by the researcher in line with expert opinion while preparing the psychoeducation program.

    Measured: tenth week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Mar 2025
  2. Study start22 Dec 2023
  3. Primary completion15 Jun 2025
  4. Study completion15 Sep 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
This research was conducted using a Parallel Convergent Mixed Methods Design to simultaneously evaluate the effectiveness of a logotherapy-based psychoeducation program through both statistical generalizations and an in-depth understanding of participants' psychoeducation experiences. The quantitative dimension of the study was designed as a randomized controlled trial (RCT) to examine the cause-and-effect relationship between the psychoeducation program and participant outcomes with a high level of evidential power. In the qualitative dimension, a phenomenological method was used to reveal the essence and shared meaning of participants' experiences during the psychoeducation program. The sample consisted of 40 family members of individuals diagnosed with schizophrenia, 19 in the experimental group and 21 in the control group.
Masking
Single blind
Who is masked
Investigator
Enrolment
42 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06859112
Sponsor's protocol ID
61351342Ekim/2022 21
Status last verified
Jun 2026
First submitted
30 Dec 2024
Last updated
22 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The data analysis will be shared. Documents (surveys, examples from transcripts) will be shared if necessary. However, due to the confidentiality of personal information, participants' personal information cannot be shared.

Publications

  • Frankl VE. Logotherapy. Isr Ann Psychiatr Relat Discip. 1967;5(2):142-55. No abstract available.

    PubMed 5247330
  • Eskigulek Y, Kav S. Effect of logotherapy counseling program on chronic sorrow, dignity, and meaning in life of palliative care patients: a randomized controlled trial. Support Care Cancer. 2024 Aug 13;32(9):587. doi: 10.1007/s00520-024-08792-w.

    PubMed 39138762
  • Aydin R, Kabukcuoglu K. The effect of logotherapy-based, nurse-guided meaning attribution conversations on women diagnosed with gynecologic cancer: A Turkish pilot study. Women Health. 2023 Sep 14;63(8):599-614. doi: 10.1080/03630242.2023.2249123. Epub 2023 Aug 29.

    PubMed 37642347
  • Sun FK, Hung CM, Yao Y, Fu CF, Tsai PJ, Chiang CY. The Effects of Logotherapy on Distress, Depression, and Demoralization in Breast Cancer and Gynecological Cancer Patients: A Preliminary Study. Cancer Nurs. 2021 Jan/Feb;44(1):53-61. doi: 10.1097/NCC.0000000000000740.

    PubMed 31469671
  • Applebaum AJ, Buda KL, Schofield E, Farberov M, Teitelbaum ND, Evans K, Cowens-Alvarado R, Cannady RS. Exploring the cancer caregiver's journey through web-based Meaning-Centered Psychotherapy. Psychooncology. 2018 Mar;27(3):847-856. doi: 10.1002/pon.4583. Epub 2017 Dec 19.

    PubMed 29136682
  • Yang X, Zhang P, Jing S, Cheng Y, Cavaletto A. Logotherapy-Based Interventions for Chinese Family Caregivers of Older Adults with Dementia Through Online Groups: A Mixed-Methods Study. J Gerontol Soc Work. 2024 Oct;67(7):865-880. doi: 10.1080/01634372.2024.2326689. Epub 2024 Mar 10.

    PubMed 38461440

Questions about this trial

What is this clinical trial studying?

A study testing logotherapy focused psychoeducation in people with Family Members and Healthy, run by aslı zeynep sipahi at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Finding meaning in life scale score (time frame: first week and eighth week). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06859112, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in